drugset / Trial / NCT06583343

Effect of Botulinum Toxin on Selective Motor Control and Pain in Diplegic Cerebral Palsy

NCT06583343

Phase 4 Completed 40 enrolled Gaziosmanpasa Research and Education Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to investigate the effects of Botulinum Neurotoxin-A (BoNT-A) injection applied to spastic muscles on pain sensation and Selective Motor Control (SMC) in cases diagnosed with diplegic spastic Cerebral Palsy.

Timeline

Start
2022-06-25
Primary completion
2023-05-25
Completion
2024-04-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic Intramuscular

Indications